Cargando…

Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study

OBJECTIVES: The aim of this study was to examine the natural history of brain involvement in adult-onset myotonic dystrophies type 1 and 2 (DM1, DM2). METHODS: We conducted a longitudinal observational study to examine functional and structural cerebral changes in myotonic dystrophies. We enrolled 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Gliem, Carla, Minnerop, Martina, Roeske, Sandra, Gärtner, Hanna, Schoene-Bake, Jan-Christoph, Adler, Sandra, Witt, Juri-Alexander, Hoffstaedter, Felix, Schneider-Gold, Christiane, Betz, Regina C., Helmstaedter, Christoph, Tittgemeyer, Marc, Amunts, Katrin, Klockgether, Thomas, Weber, Bernd, Kornblum, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405094/
https://www.ncbi.nlm.nih.gov/pubmed/30845252
http://dx.doi.org/10.1371/journal.pone.0213381
_version_ 1783401011433439232
author Gliem, Carla
Minnerop, Martina
Roeske, Sandra
Gärtner, Hanna
Schoene-Bake, Jan-Christoph
Adler, Sandra
Witt, Juri-Alexander
Hoffstaedter, Felix
Schneider-Gold, Christiane
Betz, Regina C.
Helmstaedter, Christoph
Tittgemeyer, Marc
Amunts, Katrin
Klockgether, Thomas
Weber, Bernd
Kornblum, Cornelia
author_facet Gliem, Carla
Minnerop, Martina
Roeske, Sandra
Gärtner, Hanna
Schoene-Bake, Jan-Christoph
Adler, Sandra
Witt, Juri-Alexander
Hoffstaedter, Felix
Schneider-Gold, Christiane
Betz, Regina C.
Helmstaedter, Christoph
Tittgemeyer, Marc
Amunts, Katrin
Klockgether, Thomas
Weber, Bernd
Kornblum, Cornelia
author_sort Gliem, Carla
collection PubMed
description OBJECTIVES: The aim of this study was to examine the natural history of brain involvement in adult-onset myotonic dystrophies type 1 and 2 (DM1, DM2). METHODS: We conducted a longitudinal observational study to examine functional and structural cerebral changes in myotonic dystrophies. We enrolled 16 adult-onset DM1 patients, 16 DM2 patients, and 17 controls. At baseline and after 5.5 ± 0.4 years participants underwent neurological, neuropsychological, and 3T-brain MRI examinations using identical study protocols that included voxel-based morphometry and diffusion tensor imaging. Data were analyzed by (i) group comparisons between patients and controls at baseline and follow-up, and (ii) group comparisons using difference maps (baseline–follow-up in each participant) to focus on disease-related effects over time. RESULTS: We found minor neuropsychological deficits with mild progression in DM1 more than DM2. Daytime sleepiness was restricted to DM1, whereas fatigue was present in both disease entities and stable over time. Comparing results of cross-sectional neuroimaging analyses at baseline and follow-up revealed an unchanged pattern of pronounced white matter alterations in DM1. There was mild additional gray matter reduction in DM1 at follow-up. In DM2, white matter reduction was of lesser extent, but there were some additional alterations at follow-up. Gray matter seemed unaffected in DM2. Intriguingly, longitudinal analyses using difference maps and comparing them between patients and controls did not reveal any significant differences of cerebral changes over time between patients and controls. CONCLUSION: The lack of significant disease-related progression of gray and white matter involvement over a period of five years in our cohort of DM1 and DM2 patients suggests either a rather slowly progressive process or even a stable course of cerebral changes in middle-aged adult-onset patients. Being the first longitudinal neuroimaging trial in DM1 and DM2, this study provides useful additional information regarding the natural history of brain involvement.
format Online
Article
Text
id pubmed-6405094
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-64050942019-03-17 Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study Gliem, Carla Minnerop, Martina Roeske, Sandra Gärtner, Hanna Schoene-Bake, Jan-Christoph Adler, Sandra Witt, Juri-Alexander Hoffstaedter, Felix Schneider-Gold, Christiane Betz, Regina C. Helmstaedter, Christoph Tittgemeyer, Marc Amunts, Katrin Klockgether, Thomas Weber, Bernd Kornblum, Cornelia PLoS One Research Article OBJECTIVES: The aim of this study was to examine the natural history of brain involvement in adult-onset myotonic dystrophies type 1 and 2 (DM1, DM2). METHODS: We conducted a longitudinal observational study to examine functional and structural cerebral changes in myotonic dystrophies. We enrolled 16 adult-onset DM1 patients, 16 DM2 patients, and 17 controls. At baseline and after 5.5 ± 0.4 years participants underwent neurological, neuropsychological, and 3T-brain MRI examinations using identical study protocols that included voxel-based morphometry and diffusion tensor imaging. Data were analyzed by (i) group comparisons between patients and controls at baseline and follow-up, and (ii) group comparisons using difference maps (baseline–follow-up in each participant) to focus on disease-related effects over time. RESULTS: We found minor neuropsychological deficits with mild progression in DM1 more than DM2. Daytime sleepiness was restricted to DM1, whereas fatigue was present in both disease entities and stable over time. Comparing results of cross-sectional neuroimaging analyses at baseline and follow-up revealed an unchanged pattern of pronounced white matter alterations in DM1. There was mild additional gray matter reduction in DM1 at follow-up. In DM2, white matter reduction was of lesser extent, but there were some additional alterations at follow-up. Gray matter seemed unaffected in DM2. Intriguingly, longitudinal analyses using difference maps and comparing them between patients and controls did not reveal any significant differences of cerebral changes over time between patients and controls. CONCLUSION: The lack of significant disease-related progression of gray and white matter involvement over a period of five years in our cohort of DM1 and DM2 patients suggests either a rather slowly progressive process or even a stable course of cerebral changes in middle-aged adult-onset patients. Being the first longitudinal neuroimaging trial in DM1 and DM2, this study provides useful additional information regarding the natural history of brain involvement. Public Library of Science 2019-03-07 /pmc/articles/PMC6405094/ /pubmed/30845252 http://dx.doi.org/10.1371/journal.pone.0213381 Text en © 2019 Gliem et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Gliem, Carla
Minnerop, Martina
Roeske, Sandra
Gärtner, Hanna
Schoene-Bake, Jan-Christoph
Adler, Sandra
Witt, Juri-Alexander
Hoffstaedter, Felix
Schneider-Gold, Christiane
Betz, Regina C.
Helmstaedter, Christoph
Tittgemeyer, Marc
Amunts, Katrin
Klockgether, Thomas
Weber, Bernd
Kornblum, Cornelia
Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study
title Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study
title_full Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study
title_fullStr Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study
title_full_unstemmed Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study
title_short Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study
title_sort tracking the brain in myotonic dystrophies: a 5-year longitudinal follow-up study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405094/
https://www.ncbi.nlm.nih.gov/pubmed/30845252
http://dx.doi.org/10.1371/journal.pone.0213381
work_keys_str_mv AT gliemcarla trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT minneropmartina trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT roeskesandra trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT gartnerhanna trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT schoenebakejanchristoph trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT adlersandra trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT wittjurialexander trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT hoffstaedterfelix trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT schneidergoldchristiane trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT betzreginac trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT helmstaedterchristoph trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT tittgemeyermarc trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT amuntskatrin trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT klockgetherthomas trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT weberbernd trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy
AT kornblumcornelia trackingthebraininmyotonicdystrophiesa5yearlongitudinalfollowupstudy